Marta Poves-Zafra

Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody-drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 19, 2025

Patient selection for triplet therapy with darolutamide in metastatic castration-sensitive prostate cancer and patterns of administration: a Spanish multicenter study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 28, 2025

Functional characterization of splice variants in hereditary breast and ovarian cancer susceptibility genes.

Journal: Familial cancer

Published: August 10, 2025

Is mortality truly higher for oncology patients admitted to intensive care units? A matched cohort observational study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 09, 2025

Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 07, 2025

Genetic testing for hereditary breast and ovarian cancer in the Murcian population using a comprehensive NGS panel.

Journal: Familial cancer

Published: March 26, 2025

Early diagnosis of prostate cancer in healthy men with germline mutations in DNA Damage Response (DDR) pathways: A literature review and proposal for a screening strategy.

Journal: Actas urologicas espanolas

Published: November 11, 2024

SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 15, 2024

Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia.

Journal: Advances in laboratory medicine

Published: March 15, 2023

Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody-drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology.

Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody-drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology.

Patient selection for triplet therapy with darolutamide in metastatic castration-sensitive prostate cancer and patterns of administration: a Spanish multicenter study.

Patient selection for triplet therapy with darolutamide in metastatic castration-sensitive prostate cancer and patterns of administration: a Spanish multicenter study.

Functional characterization of splice variants in hereditary breast and ovarian cancer susceptibility genes.

Functional characterization of splice variants in hereditary breast and ovarian cancer susceptibility genes.

Is mortality truly higher for oncology patients admitted to intensive care units? A matched cohort observational study.

Is mortality truly higher for oncology patients admitted to intensive care units? A matched cohort observational study.

Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial.

Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial.

Genetic testing for hereditary breast and ovarian cancer in the Murcian population using a comprehensive NGS panel.

Genetic testing for hereditary breast and ovarian cancer in the Murcian population using a comprehensive NGS panel.

Early diagnosis of prostate cancer in healthy men with germline mutations in DNA Damage Response (DDR) pathways: A literature review and proposal for a screening strategy.

Early diagnosis of prostate cancer in healthy men with germline mutations in DNA Damage Response (DDR) pathways: A literature review and proposal for a screening strategy.

SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023).

SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023).

Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia.

Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia.

Title Not Found

Title Not Found

Psychological factors and prognostic communication preferences in advanced cancer: multicentre study.

Psychological factors and prognostic communication preferences in advanced cancer: multicentre study.

A prognostic model to identify short survival expectancy of medical oncology patients at the time of hospital discharge.

A prognostic model to identify short survival expectancy of medical oncology patients at the time of hospital discharge.